How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Armed conflict in eastern Ukraine erupted in early 2014 following Russia’s annexation of Crimea. The previous year, protests in Ukraine’s capital, Kyiv, against Ukrainian President Viktor Yanukovych’s ...

Roshini Raj, MD, is Health's former magazine's medical editor and coauthor of What the Yuck?!. Board-certified in gastroenterology and internal medicine, Dr. Raj is a Clinical Associate Professor of ...